YFP-DAXX-mSIM1/2
(Plasmid
#134525)
-
PurposeExpresses YFP-DAXX fusion protein with a mutations in both its 5' and 3' SIMs
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 134525 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEYFP
-
Backbone manufacturerClontech
- Backbone size w/o insert (bp) 4700
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameDAXX-mSIM1/2
-
SpeciesH. sapiens (human)
-
MutationSIM (IIVL) 7-10 aa changed to IGAG and SIM (IIVL) 733-736 aa changed to IGAG
- Promoter CMV
-
Tag
/ Fusion Protein
- YFP (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer EGFP-C
- 3′ sequencing primer SV40pA-R (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byRoger Everett
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
YFP-DAXX-mSIM1/2 was a gift from Susan Janicki (Addgene plasmid # 134525 ; http://n2t.net/addgene:134525 ; RRID:Addgene_134525) -
For your References section:
PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly. Shastrula PK, Sierra I, Deng Z, Keeney F, Hayden JE, Lieberman PM, Janicki SM. J Cell Sci. 2019 Mar 26;132(6). pii: jcs.220970. doi: 10.1242/jcs.220970. 10.1242/jcs.220970 PubMed 30796101